Oxford Biomedica PLC Holding(s) in Company (9981P)
13 October 2023 - 5:00PM
UK Regulatory
TIDMOXB
RNS Number : 9981P
Oxford Biomedica PLC
13 October 2023
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BDFBVT43
Issuer Name
OXFORD BIOMEDICA PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Institut Merieux SA
City of registered office (if applicable)
Lyon
Country of registered office (if applicable)
France
4. Details of the shareholder
Name City of registered office Country of registered office
Natixis Paris France
=========================== ==============================
5. Date on which the threshold was crossed or reached
10-Oct-2023
6. Date on which Issuer notified
12-Oct-2023
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 3.099950 0.000000 3.099950 3000000
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable)
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BDFBVT43 3000000 0 3.099950 0.000000
====================== ====================== ====================== ======================
Sub Total 8.A 3000000 3.099950%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
Institut Merieux SA TSGH SAS 3.099950 0.000000 3.099950%
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
TSGH SAS (a wholly owned subsidiary of Institut Merieux SA)
holds the shares in Oxford Biomedica Plc through a securities
account of the French corporate and investment bank, Natixis (the
"Shareholder"). Institut Merieux SA has control and discretion over
the voting rights attaching to the shares of Oxford Biomedica Plc,
which are held by the Shareholder, through its ownership of the
equity of TSGH SAS.
12. Date of Completion
12-Oct-2023
13. Place Of Completion
United Kingdom
Contact name: Natalie Walter
Contact phone number: 01865 783 000
---------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUUORROKURAUA
(END) Dow Jones Newswires
October 13, 2023 02:00 ET (06:00 GMT)
Oxford Biomedica (AQSE:OXB.GB)
Historical Stock Chart
From Dec 2024 to Jan 2025
Oxford Biomedica (AQSE:OXB.GB)
Historical Stock Chart
From Jan 2024 to Jan 2025
